

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 5.54606743 |
| 2 | cytidine catabolic process (GO:0006216) | 5.54606743 |
| 3 | cytidine deamination (GO:0009972) | 5.54606743 |
| 4 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.33779613 |
| 5 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.89015468 |
| 6 | DNA deamination (GO:0045006) | 4.71188146 |
| 7 | behavioral response to nicotine (GO:0035095) | 4.61725451 |
| 8 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.16632882 |
| 9 | regulation of chronic inflammatory response (GO:0002676) | 4.08547840 |
| 10 | sequestering of actin monomers (GO:0042989) | 4.05975703 |
| 11 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.96503142 |
| 12 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.96503142 |
| 13 | iron-sulfur cluster assembly (GO:0016226) | 3.78722492 |
| 14 | metallo-sulfur cluster assembly (GO:0031163) | 3.78722492 |
| 15 | DNA double-strand break processing (GO:0000729) | 3.77434788 |
| 16 | protein neddylation (GO:0045116) | 3.73391819 |
| 17 | auditory receptor cell stereocilium organization (GO:0060088) | 3.54737018 |
| 18 | protein-cofactor linkage (GO:0018065) | 3.53773841 |
| 19 | negative regulation of mast cell activation (GO:0033004) | 3.51682307 |
| 20 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.48241081 |
| 21 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.46715805 |
| 22 | L-fucose catabolic process (GO:0042355) | 3.43856724 |
| 23 | fucose catabolic process (GO:0019317) | 3.43856724 |
| 24 | L-fucose metabolic process (GO:0042354) | 3.43856724 |
| 25 | DNA demethylation (GO:0080111) | 3.37866976 |
| 26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.34933144 |
| 27 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.27847277 |
| 28 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.24477763 |
| 29 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.23402001 |
| 30 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.20143911 |
| 31 | ATP synthesis coupled proton transport (GO:0015986) | 3.20143911 |
| 32 | DNA dealkylation (GO:0035510) | 3.15736705 |
| 33 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.15713392 |
| 34 | dopamine transport (GO:0015872) | 3.11788027 |
| 35 | respiratory electron transport chain (GO:0022904) | 3.11309346 |
| 36 | electron transport chain (GO:0022900) | 3.07462355 |
| 37 | platelet dense granule organization (GO:0060155) | 3.06355778 |
| 38 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.03739142 |
| 39 | cullin deneddylation (GO:0010388) | 3.00807547 |
| 40 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.00374614 |
| 41 | rRNA modification (GO:0000154) | 2.99947622 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.98986304 |
| 43 | epithelial cilium movement (GO:0003351) | 2.98352262 |
| 44 | isoprenoid biosynthetic process (GO:0008299) | 2.94293801 |
| 45 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.94284798 |
| 46 | response to inactivity (GO:0014854) | 2.93895735 |
| 47 | proteasome assembly (GO:0043248) | 2.91914520 |
| 48 | regulation of interleukin-8 secretion (GO:2000482) | 2.90091975 |
| 49 | ubiquinone metabolic process (GO:0006743) | 2.89713795 |
| 50 | intraciliary transport (GO:0042073) | 2.89490662 |
| 51 | photoreceptor cell development (GO:0042461) | 2.89139443 |
| 52 | transmission of nerve impulse (GO:0019226) | 2.89035747 |
| 53 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.88079069 |
| 54 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.88079069 |
| 55 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.88079069 |
| 56 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.85201656 |
| 57 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.82145565 |
| 58 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.81085249 |
| 59 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.81085249 |
| 60 | somite development (GO:0061053) | 2.80143160 |
| 61 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.78960386 |
| 62 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.78584354 |
| 63 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.75380434 |
| 64 | detection of light stimulus involved in visual perception (GO:0050908) | 2.75380434 |
| 65 | protein complex biogenesis (GO:0070271) | 2.74001917 |
| 66 | terpenoid biosynthetic process (GO:0016114) | 2.72970812 |
| 67 | ubiquinone biosynthetic process (GO:0006744) | 2.72770372 |
| 68 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.71867594 |
| 69 | regulation of regulatory T cell differentiation (GO:0045589) | 2.70976867 |
| 70 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.70283416 |
| 71 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.70283416 |
| 72 | positive regulation of defense response to virus by host (GO:0002230) | 2.68518961 |
| 73 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.68378753 |
| 74 | mechanosensory behavior (GO:0007638) | 2.67633431 |
| 75 | activated T cell proliferation (GO:0050798) | 2.65345637 |
| 76 | GPI anchor metabolic process (GO:0006505) | 2.63940523 |
| 77 | eye photoreceptor cell development (GO:0042462) | 2.63578717 |
| 78 | negative regulation of B cell proliferation (GO:0030889) | 2.63173309 |
| 79 | pseudouridine synthesis (GO:0001522) | 2.60420735 |
| 80 | base-excision repair, AP site formation (GO:0006285) | 2.58073846 |
| 81 | ribosomal small subunit assembly (GO:0000028) | 2.57462260 |
| 82 | rRNA methylation (GO:0031167) | 2.57070981 |
| 83 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.56993596 |
| 84 | protein deneddylation (GO:0000338) | 2.54114569 |
| 85 | inner ear receptor stereocilium organization (GO:0060122) | 2.53968913 |
| 86 | intestinal epithelial cell development (GO:0060576) | 2.52567894 |
| 87 | cyclooxygenase pathway (GO:0019371) | 2.50328886 |
| 88 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.49162410 |
| 89 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.47888629 |
| 90 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.47788149 |
| 91 | spinal cord association neuron differentiation (GO:0021527) | 2.47437497 |
| 92 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.43774030 |
| 93 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.43694305 |
| 94 | NADH dehydrogenase complex assembly (GO:0010257) | 2.43694305 |
| 95 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.43694305 |
| 96 | parturition (GO:0007567) | 2.41940985 |
| 97 | synaptic transmission, cholinergic (GO:0007271) | 2.41803231 |
| 98 | regulation of action potential (GO:0098900) | 2.41298055 |
| 99 | regulation of T cell chemotaxis (GO:0010819) | 2.41229324 |
| 100 | positive regulation of T cell chemotaxis (GO:0010820) | 2.41229324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.41650782 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.68950543 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.61662894 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.29815558 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.23683491 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.09015468 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.07312940 |
| 8 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.81760847 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.65997673 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.65242693 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.59523453 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.43834860 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.35964674 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.31387508 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.05918782 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.94303192 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.92486761 |
| 18 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.92462430 |
| 19 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.89283084 |
| 20 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.86976199 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.82109622 |
| 22 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.78528652 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.75863470 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64808148 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64167713 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.63944964 |
| 27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.59735293 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.59039452 |
| 29 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.55406613 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.51146819 |
| 31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50973646 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48716534 |
| 33 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45147696 |
| 34 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.42741213 |
| 35 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.42390034 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.40146839 |
| 37 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.37039305 |
| 38 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.37039305 |
| 39 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.32106821 |
| 40 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31688135 |
| 41 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.30655900 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30551500 |
| 43 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.28744972 |
| 44 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.28446659 |
| 45 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.28047643 |
| 46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.26332123 |
| 47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.25391925 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24120273 |
| 49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.22577796 |
| 50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21492010 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20500691 |
| 52 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.20233839 |
| 53 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.20233839 |
| 54 | FUS_26573619_Chip-Seq_HEK293_Human | 1.20034197 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.19866597 |
| 56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19368863 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15631330 |
| 58 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.14622729 |
| 59 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13918112 |
| 60 | AR_20517297_ChIP-Seq_VCAP_Human | 1.12900784 |
| 61 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.12312670 |
| 62 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.12136192 |
| 63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10969121 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10969121 |
| 65 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10173434 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08324162 |
| 67 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.08299661 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07668767 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06922217 |
| 70 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06737137 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04828257 |
| 72 | NCOR_22424771_ChIP-Seq_293T_Human | 1.04767864 |
| 73 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04393082 |
| 74 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04058493 |
| 75 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03877847 |
| 76 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.03028376 |
| 77 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02050144 |
| 78 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.01652660 |
| 79 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.01434818 |
| 80 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99790333 |
| 81 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97857562 |
| 82 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95695137 |
| 83 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.95685366 |
| 84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95588623 |
| 85 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94367556 |
| 86 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.93239330 |
| 87 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.92975599 |
| 88 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92082007 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91083890 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90653543 |
| 91 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.90075707 |
| 92 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89487189 |
| 93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88740066 |
| 94 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88373689 |
| 95 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.88134062 |
| 96 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87847952 |
| 97 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.87705711 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87402554 |
| 99 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86584402 |
| 100 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.85503539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005645_abnormal_hypothalamus_physiol | 4.19262901 |
| 2 | MP0002102_abnormal_ear_morphology | 3.11572576 |
| 3 | MP0005671_abnormal_response_to | 2.65969279 |
| 4 | MP0004147_increased_porphyrin_level | 2.54516899 |
| 5 | MP0000372_irregular_coat_pigmentation | 2.21934096 |
| 6 | MP0003880_abnormal_central_pattern | 2.11852234 |
| 7 | MP0004885_abnormal_endolymph | 2.08526950 |
| 8 | MP0006276_abnormal_autonomic_nervous | 2.08107689 |
| 9 | MP0006292_abnormal_olfactory_placode | 2.05374723 |
| 10 | MP0001529_abnormal_vocalization | 2.04297497 |
| 11 | MP0009785_altered_susceptibility_to | 1.99776072 |
| 12 | MP0002653_abnormal_ependyma_morphology | 1.99247558 |
| 13 | MP0005551_abnormal_eye_electrophysiolog | 1.95538229 |
| 14 | MP0002272_abnormal_nervous_system | 1.88343983 |
| 15 | MP0002876_abnormal_thyroid_physiology | 1.86387563 |
| 16 | MP0003011_delayed_dark_adaptation | 1.84440473 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 1.81983116 |
| 18 | MP0001873_stomach_inflammation | 1.78121052 |
| 19 | MP0001919_abnormal_reproductive_system | 1.76970754 |
| 20 | MP0006072_abnormal_retinal_apoptosis | 1.76134930 |
| 21 | MP0008872_abnormal_physiological_respon | 1.65278273 |
| 22 | MP0003878_abnormal_ear_physiology | 1.64715865 |
| 23 | MP0005377_hearing/vestibular/ear_phenot | 1.64715865 |
| 24 | MP0004142_abnormal_muscle_tone | 1.64209115 |
| 25 | MP0002163_abnormal_gland_morphology | 1.63441971 |
| 26 | MP0001986_abnormal_taste_sensitivity | 1.60243531 |
| 27 | MP0001486_abnormal_startle_reflex | 1.56159289 |
| 28 | MP0003136_yellow_coat_color | 1.55894243 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.54379222 |
| 30 | MP0005389_reproductive_system_phenotype | 1.51246429 |
| 31 | MP0004742_abnormal_vestibular_system | 1.50533777 |
| 32 | MP0001905_abnormal_dopamine_level | 1.48768347 |
| 33 | MP0005253_abnormal_eye_physiology | 1.46983654 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.44768374 |
| 35 | MP0009745_abnormal_behavioral_response | 1.44481161 |
| 36 | MP0008995_early_reproductive_senescence | 1.41616378 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.40768508 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.40732522 |
| 39 | MP0002234_abnormal_pharynx_morphology | 1.40212733 |
| 40 | MP0008789_abnormal_olfactory_epithelium | 1.38985394 |
| 41 | MP0003866_abnormal_defecation | 1.37811006 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.34213200 |
| 43 | MP0002095_abnormal_skin_pigmentation | 1.31575920 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.27131436 |
| 45 | MP0001485_abnormal_pinna_reflex | 1.26354582 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.25923361 |
| 47 | MP0001970_abnormal_pain_threshold | 1.24387780 |
| 48 | MP0002933_joint_inflammation | 1.21927181 |
| 49 | MP0001188_hyperpigmentation | 1.20927664 |
| 50 | MP0003195_calcinosis | 1.20680869 |
| 51 | MP0009764_decreased_sensitivity_to | 1.19643933 |
| 52 | MP0008877_abnormal_DNA_methylation | 1.18548724 |
| 53 | MP0002822_catalepsy | 1.11213048 |
| 54 | MP0003787_abnormal_imprinting | 1.10695799 |
| 55 | MP0002733_abnormal_thermal_nociception | 1.10303835 |
| 56 | MP0001542_abnormal_bone_strength | 1.09023276 |
| 57 | MP0000026_abnormal_inner_ear | 1.09020143 |
| 58 | MP0005387_immune_system_phenotype | 1.08535813 |
| 59 | MP0001790_abnormal_immune_system | 1.08535813 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.07796094 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.06201830 |
| 62 | MP0002752_abnormal_somatic_nervous | 1.05423657 |
| 63 | MP0002282_abnormal_trachea_morphology | 1.05244015 |
| 64 | MP0003646_muscle_fatigue | 1.05014880 |
| 65 | MP0002572_abnormal_emotion/affect_behav | 1.02573872 |
| 66 | MP0000049_abnormal_middle_ear | 1.02344940 |
| 67 | MP0003724_increased_susceptibility_to | 1.00415220 |
| 68 | MP0010386_abnormal_urinary_bladder | 0.99790553 |
| 69 | MP0001963_abnormal_hearing_physiology | 0.99637553 |
| 70 | MP0003938_abnormal_ear_development | 0.97953441 |
| 71 | MP0005499_abnormal_olfactory_system | 0.97848913 |
| 72 | MP0005394_taste/olfaction_phenotype | 0.97848913 |
| 73 | MP0009046_muscle_twitch | 0.97736079 |
| 74 | MP0005195_abnormal_posterior_eye | 0.95023446 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.94030171 |
| 76 | MP0001800_abnormal_humoral_immune | 0.93857433 |
| 77 | MP0001324_abnormal_eye_pigmentation | 0.93225511 |
| 78 | MP0005000_abnormal_immune_tolerance | 0.92676604 |
| 79 | MP0002735_abnormal_chemical_nociception | 0.92496438 |
| 80 | MP0002184_abnormal_innervation | 0.92174079 |
| 81 | MP0002063_abnormal_learning/memory/cond | 0.91878649 |
| 82 | MP0000631_abnormal_neuroendocrine_gland | 0.91776831 |
| 83 | MP0001764_abnormal_homeostasis | 0.91624997 |
| 84 | MP0002557_abnormal_social/conspecific_i | 0.91250574 |
| 85 | MP0001835_abnormal_antigen_presentation | 0.90363058 |
| 86 | MP0002751_abnormal_autonomic_nervous | 0.88620385 |
| 87 | MP0000647_abnormal_sebaceous_gland | 0.87777812 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.86854597 |
| 89 | MP0005187_abnormal_penis_morphology | 0.86448420 |
| 90 | MP0003567_abnormal_fetal_cardiomyocyte | 0.85485000 |
| 91 | MP0002734_abnormal_mechanical_nocicepti | 0.84939032 |
| 92 | MP0002160_abnormal_reproductive_system | 0.84308843 |
| 93 | MP0003635_abnormal_synaptic_transmissio | 0.83260916 |
| 94 | MP0005379_endocrine/exocrine_gland_phen | 0.82515187 |
| 95 | MP0009379_abnormal_foot_pigmentation | 0.82185678 |
| 96 | MP0003718_maternal_effect | 0.79785783 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.79205212 |
| 98 | MP0000685_abnormal_immune_system | 0.79092703 |
| 99 | MP0002736_abnormal_nociception_after | 0.78613477 |
| 100 | MP0005310_abnormal_salivary_gland | 0.77728415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.49166980 |
| 2 | Abnormality of midbrain morphology (HP:0002418) | 4.05281035 |
| 3 | Molar tooth sign on MRI (HP:0002419) | 4.05281035 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.04062562 |
| 5 | Acute encephalopathy (HP:0006846) | 4.00510932 |
| 6 | Progressive macrocephaly (HP:0004481) | 3.89446464 |
| 7 | Abnormality of the prostate (HP:0008775) | 3.59323484 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.47604103 |
| 9 | IgG deficiency (HP:0004315) | 3.32221423 |
| 10 | Nephronophthisis (HP:0000090) | 3.26657733 |
| 11 | Abnormality of B cell number (HP:0010975) | 3.23871895 |
| 12 | Increased CSF lactate (HP:0002490) | 3.23663919 |
| 13 | Lipid accumulation in hepatocytes (HP:0006561) | 3.13880658 |
| 14 | Retinal dysplasia (HP:0007973) | 3.05063875 |
| 15 | Medial flaring of the eyebrow (HP:0010747) | 3.00597672 |
| 16 | Type II lissencephaly (HP:0007260) | 2.99240913 |
| 17 | Decreased central vision (HP:0007663) | 2.97237870 |
| 18 | Methylmalonic acidemia (HP:0002912) | 2.97183816 |
| 19 | True hermaphroditism (HP:0010459) | 2.94981108 |
| 20 | Congenital stationary night blindness (HP:0007642) | 2.91011230 |
| 21 | Pancreatic cysts (HP:0001737) | 2.85065083 |
| 22 | Stomach cancer (HP:0012126) | 2.81127594 |
| 23 | Hypoplasia of the pons (HP:0012110) | 2.72133406 |
| 24 | Increased hepatocellular lipid droplets (HP:0006565) | 2.71195052 |
| 25 | B lymphocytopenia (HP:0010976) | 2.69255387 |
| 26 | Abnormality of the renal medulla (HP:0100957) | 2.65841847 |
| 27 | Optic disc pallor (HP:0000543) | 2.65699306 |
| 28 | Cerebral edema (HP:0002181) | 2.62298280 |
| 29 | Hepatocellular necrosis (HP:0001404) | 2.60517462 |
| 30 | Pancreatic fibrosis (HP:0100732) | 2.55509747 |
| 31 | Increased intramyocellular lipid droplets (HP:0012240) | 2.54554952 |
| 32 | Abnormality of the pons (HP:0007361) | 2.48709125 |
| 33 | Increased muscle lipid content (HP:0009058) | 2.47464425 |
| 34 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.45194405 |
| 35 | Hepatic necrosis (HP:0002605) | 2.42778387 |
| 36 | Severe combined immunodeficiency (HP:0004430) | 2.42664139 |
| 37 | Hypoproteinemia (HP:0003075) | 2.41017872 |
| 38 | Type 2 muscle fiber atrophy (HP:0003554) | 2.40869714 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 2.36220885 |
| 40 | Methylmalonic aciduria (HP:0012120) | 2.31387696 |
| 41 | Thyroid-stimulating hormone excess (HP:0002925) | 2.29981987 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.29417498 |
| 43 | Lethargy (HP:0001254) | 2.26832068 |
| 44 | Abnormality of male internal genitalia (HP:0000022) | 2.26740494 |
| 45 | Abolished electroretinogram (ERG) (HP:0000550) | 2.23005713 |
| 46 | Increased serum lactate (HP:0002151) | 2.21779221 |
| 47 | Hemoptysis (HP:0002105) | 2.19466011 |
| 48 | Attenuation of retinal blood vessels (HP:0007843) | 2.17219304 |
| 49 | 3-Methylglutaconic aciduria (HP:0003535) | 2.16031082 |
| 50 | Sclerocornea (HP:0000647) | 2.15667097 |
| 51 | Lactic acidosis (HP:0003128) | 2.14766254 |
| 52 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.12314734 |
| 53 | Thyroiditis (HP:0100646) | 2.10260726 |
| 54 | Ureteral stenosis (HP:0000071) | 2.09422807 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.09023482 |
| 56 | Congenital, generalized hypertrichosis (HP:0004540) | 2.08540879 |
| 57 | Lissencephaly (HP:0001339) | 2.05943133 |
| 58 | Seborrheic dermatitis (HP:0001051) | 2.05541583 |
| 59 | Ketoacidosis (HP:0001993) | 2.03853719 |
| 60 | Leukodystrophy (HP:0002415) | 2.03422896 |
| 61 | Gait imbalance (HP:0002141) | 2.02152054 |
| 62 | Increased IgM level (HP:0003496) | 1.99153137 |
| 63 | Tachypnea (HP:0002789) | 1.96219173 |
| 64 | Delayed CNS myelination (HP:0002188) | 1.95295688 |
| 65 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95161077 |
| 66 | Gangrene (HP:0100758) | 1.92659140 |
| 67 | Abnormality of the renal cortex (HP:0011035) | 1.92258071 |
| 68 | Congenital primary aphakia (HP:0007707) | 1.91384695 |
| 69 | Progressive cerebellar ataxia (HP:0002073) | 1.90319454 |
| 70 | Rib fusion (HP:0000902) | 1.89966038 |
| 71 | Gaze-evoked nystagmus (HP:0000640) | 1.89682082 |
| 72 | Hypoplasia of the uterus (HP:0000013) | 1.89657256 |
| 73 | Hypomagnesemia (HP:0002917) | 1.89498533 |
| 74 | Pendular nystagmus (HP:0012043) | 1.87724617 |
| 75 | Broad-based gait (HP:0002136) | 1.87389148 |
| 76 | Autoimmune thrombocytopenia (HP:0001973) | 1.87131547 |
| 77 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.86980898 |
| 78 | Respiratory failure (HP:0002878) | 1.86371589 |
| 79 | Ureteral obstruction (HP:0006000) | 1.85553866 |
| 80 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.84058971 |
| 81 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.82014301 |
| 82 | Abnormality of eosinophils (HP:0001879) | 1.80996766 |
| 83 | Chest pain (HP:0100749) | 1.79783468 |
| 84 | Agitation (HP:0000713) | 1.79717528 |
| 85 | Prostate neoplasm (HP:0100787) | 1.78679492 |
| 86 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.78580086 |
| 87 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.78580086 |
| 88 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.77551977 |
| 89 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.77551977 |
| 90 | Combined immunodeficiency (HP:0005387) | 1.77542488 |
| 91 | Cerebellar dysplasia (HP:0007033) | 1.77162086 |
| 92 | Renal Fanconi syndrome (HP:0001994) | 1.75555503 |
| 93 | Erythroderma (HP:0001019) | 1.74434353 |
| 94 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.74132558 |
| 95 | Pancreatitis (HP:0001733) | 1.74067697 |
| 96 | Concave nail (HP:0001598) | 1.73624737 |
| 97 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.72993797 |
| 98 | Postaxial hand polydactyly (HP:0001162) | 1.72583766 |
| 99 | Muscle fiber atrophy (HP:0100295) | 1.71496402 |
| 100 | Ketosis (HP:0001946) | 1.71299175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.01844594 |
| 2 | MST4 | 3.05904437 |
| 3 | BMPR1B | 2.92791793 |
| 4 | ADRBK2 | 2.72793825 |
| 5 | MAP2K7 | 2.62913399 |
| 6 | ZAK | 2.49008776 |
| 7 | BCR | 2.42444501 |
| 8 | MAP4K2 | 2.25760356 |
| 9 | STK16 | 2.23482267 |
| 10 | WNK3 | 2.14232101 |
| 11 | TAOK3 | 2.02097410 |
| 12 | FRK | 2.00911393 |
| 13 | WNK4 | 2.00877238 |
| 14 | CDK8 | 1.98404877 |
| 15 | EPHA3 | 1.91031194 |
| 16 | TLK1 | 1.88884066 |
| 17 | GRK1 | 1.85508729 |
| 18 | TRIM28 | 1.84282989 |
| 19 | MUSK | 1.81354743 |
| 20 | PINK1 | 1.75257317 |
| 21 | GRK6 | 1.66769797 |
| 22 | PIK3CA | 1.53203581 |
| 23 | RIPK4 | 1.49088199 |
| 24 | PLK2 | 1.48655660 |
| 25 | KDR | 1.43067109 |
| 26 | MAP3K4 | 1.42253565 |
| 27 | BMPR2 | 1.33761216 |
| 28 | CASK | 1.29887896 |
| 29 | MARK1 | 1.27574173 |
| 30 | VRK1 | 1.27021570 |
| 31 | MAPK13 | 1.23493301 |
| 32 | CSNK1G3 | 1.21055580 |
| 33 | NEK1 | 1.18788590 |
| 34 | VRK2 | 1.18365362 |
| 35 | PHKG1 | 1.18128483 |
| 36 | PHKG2 | 1.18128483 |
| 37 | STK39 | 1.14376870 |
| 38 | EPHA4 | 1.13316364 |
| 39 | TYRO3 | 1.12939789 |
| 40 | CSNK1G2 | 1.12558117 |
| 41 | KIT | 1.08893680 |
| 42 | BCKDK | 1.05322834 |
| 43 | CSNK1A1L | 1.03393108 |
| 44 | ITK | 1.02031104 |
| 45 | GRK7 | 0.99371722 |
| 46 | MATK | 0.95724779 |
| 47 | SRPK1 | 0.95492823 |
| 48 | SIK3 | 0.88603506 |
| 49 | CSNK1G1 | 0.87425406 |
| 50 | SYK | 0.87039550 |
| 51 | EPHB2 | 0.86917469 |
| 52 | OXSR1 | 0.86915880 |
| 53 | TSSK6 | 0.85919222 |
| 54 | IKBKB | 0.85351372 |
| 55 | NTRK2 | 0.82408265 |
| 56 | DYRK2 | 0.80946664 |
| 57 | PLK3 | 0.80113420 |
| 58 | TEC | 0.77479139 |
| 59 | OBSCN | 0.72685796 |
| 60 | FER | 0.71030576 |
| 61 | GRK5 | 0.68607154 |
| 62 | INSRR | 0.64527669 |
| 63 | PRKCG | 0.63704161 |
| 64 | NME1 | 0.63522668 |
| 65 | MAP2K2 | 0.61126287 |
| 66 | NUAK1 | 0.59000258 |
| 67 | FES | 0.58951452 |
| 68 | PRKCE | 0.58896708 |
| 69 | MINK1 | 0.57735911 |
| 70 | PRKD3 | 0.56375571 |
| 71 | CAMK2A | 0.56021339 |
| 72 | TIE1 | 0.55194817 |
| 73 | CDK19 | 0.53786835 |
| 74 | LCK | 0.53065732 |
| 75 | ERBB3 | 0.52931754 |
| 76 | PRKACA | 0.52807035 |
| 77 | CAMKK2 | 0.51538801 |
| 78 | IGF1R | 0.51251019 |
| 79 | CSNK1D | 0.49749417 |
| 80 | CSNK1A1 | 0.46974843 |
| 81 | PRKCH | 0.46884829 |
| 82 | PKN1 | 0.46080061 |
| 83 | MAPK15 | 0.45203084 |
| 84 | ADRBK1 | 0.42619575 |
| 85 | CAMK1 | 0.40814666 |
| 86 | PAK3 | 0.40670235 |
| 87 | MAP3K9 | 0.40467021 |
| 88 | MAP2K6 | 0.38466128 |
| 89 | EIF2AK2 | 0.37666861 |
| 90 | PRKCA | 0.37297144 |
| 91 | RPS6KA5 | 0.36607784 |
| 92 | PIM2 | 0.35630491 |
| 93 | BTK | 0.34184494 |
| 94 | EIF2AK3 | 0.33254496 |
| 95 | CAMK4 | 0.32014438 |
| 96 | CSF1R | 0.30922209 |
| 97 | PLK1 | 0.30902517 |
| 98 | PLK4 | 0.30666172 |
| 99 | CLK1 | 0.30043336 |
| 100 | RPS6KA4 | 0.30030646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.87813238 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.54670939 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.88022223 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.65632329 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.50492677 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.47182200 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.45808295 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.41870348 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.22783604 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.21655583 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.11530543 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.05667023 |
| 13 | Basal transcription factors_Homo sapiens_hsa03022 | 1.96979694 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.89131920 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.88382911 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.86911536 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.84825256 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.83118458 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.82382750 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82257168 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78924775 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.69834798 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.67069054 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.65340444 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.60876150 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.58857569 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55611039 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.50205832 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.49277158 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.48829601 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.44971878 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.41108373 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 1.40833351 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.28501397 |
| 35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24092233 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21579782 |
| 37 | Nicotine addiction_Homo sapiens_hsa05033 | 1.21557324 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20205313 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.18919212 |
| 40 | Olfactory transduction_Homo sapiens_hsa04740 | 1.12137978 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11633125 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.05702631 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03597440 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00037218 |
| 45 | Morphine addiction_Homo sapiens_hsa05032 | 0.99278810 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97517821 |
| 47 | GABAergic synapse_Homo sapiens_hsa04727 | 0.96439995 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.94032828 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.93364714 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87617671 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86583155 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77761201 |
| 53 | Spliceosome_Homo sapiens_hsa03040 | 0.76452914 |
| 54 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.76255030 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.74781963 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74650494 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 0.73727228 |
| 58 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73273997 |
| 59 | Mismatch repair_Homo sapiens_hsa03430 | 0.72415706 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68483238 |
| 61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67643546 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65930145 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65755190 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63527010 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62727042 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.61909503 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61776843 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60776583 |
| 69 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.60433593 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60275707 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59441668 |
| 72 | Circadian entrainment_Homo sapiens_hsa04713 | 0.59068132 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57627744 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55137723 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54609301 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.52619455 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49228714 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48555570 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47496226 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46805517 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45359885 |
| 82 | Insulin secretion_Homo sapiens_hsa04911 | 0.42009538 |
| 83 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40409258 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40191511 |
| 85 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.40097295 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39549001 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38394781 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38230457 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33101835 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.31555685 |
| 91 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.31506683 |
| 92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.29718269 |
| 93 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.27916497 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.26319637 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.24638035 |
| 96 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.24422962 |
| 97 | Base excision repair_Homo sapiens_hsa03410 | 0.22827195 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19793312 |
| 99 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.19693907 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.19261727 |

